Lextegrity’s Integrity Gateway Approvals & Disclosures and Transaction Monitoring applications were chosen in an ongoing DOJ and SEC FCPA investigation by a leading global biopharmaceutical company.

Read Now - Life Sciences Case Study

A leading global life sciences company sought to enhance compliance controls and processes amid an ongoing FCPA investigation. Lextegrity’s Integrity Gateway Approvals & Disclosures and Integrity Gateway Approvals & Disclosures applications were implemented quickly without the need for data scientists and engineers globally and in multiple languages. Compliance analytics and automation enhancements were implemented to bolster third-party risk management as well as monitor sponsorships and donations and benefits to government officials and healthcare professionals.

This case study will address:

  • checkmarkThe high-risk areas this leading biopharmaceutical company needed to address
  • checkmarkThe solution Lextegrity provided
  • checkmarkThe successful implementation of the Integrity Gateway application

Download the case study today and see how Lextegrity helped a leading life sciences company effectively address high-risk areas amid an ongoing FCPA investigation.